ALX Oncology swaps 13.35M shares from Blackstone, RA Capital, venBio for $0.001 pre-funded warrants

ALX ONCOLOGY HOLDINGS INC

Stockholders surrender 13,353,384 common shares for no consideration; ALX issues pre-funded warrants for the same 13,353,384 shares at a $0.001 exercise price.
Blackstone Annex Master Fund surrenders 12,885,891 shares; RA Capital Healthcare Fund 213,667 shares; venBio Global Strategic Fund 253,826 shares.
Exchange made under Section 3(a)(9) registration exemption; settlement on or about October 15, 2026, with Computershare instructed to cancel or re-register the shares.
Warrants exercisable at any time for cash or cashless; 4.99%/9.99% beneficial ownership blockers, adjustable up to 19.99% effective 61 days after holder notice.
Company confirms no commissions or remuneration were paid to solicit the exchange; warrants and warrant shares may carry restrictive legends.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.